A1AKN

N-(N-{(E)-[(4S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl][4-(trifluoromethyl)benzene-1-sulfonamido]methylidene}carbamimidoyl)acetamide

Created:	2024-04-04
Last modified:	2024-11-20

Find Related PDB Entry
1 entries where A1AKN is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	1
Bond Count	65
Aromatic Bond Count	18

2D diagram of A1AKN

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-(N-{(E)-[(4S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl][4-(trifluoromethyl)benzene-1-sulfonamido]methylidene}carbamimidoyl)acetamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(~{N}~{E})-~{N}-[[(4~{S})-5-(4-chlorophenyl)-4-phenyl-3,4-dihydropyrazol-2-yl]-[[4-(trifluoromethyl)phenyl]sulfonylamino]methylidene]carbamimidoyl]ethanamide
Formula	C₂₆ H₂₂ Cl F₃ N₆ O₃ S
Molecular Weight	591.004
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=S(=O)(N/C(=N/C(=N)NC(C)=O)N1CC(C(=N1)c1ccc(Cl)cc1)c1ccccc1)c1ccc(cc1)C(F)(F)F
SMILES	CACTVS	3.385	CC(=O)NC(=N)N=C(N[S](=O)(=O)c1ccc(cc1)C(F)(F)F)N2C[CH](c3ccccc3)C(=N2)c4ccc(Cl)cc4
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)NC(=N)N=C(NS(=O)(=O)c1ccc(cc1)C(F)(F)F)N2CC(C(=N2)c3ccc(cc3)Cl)c4ccccc4
Canonical SMILES	CACTVS	3.385	CC(=O)NC(=N)N=C(N[S](=O)(=O)c1ccc(cc1)C(F)(F)F)N2C[C@H](c3ccccc3)C(=N2)c4ccc(Cl)cc4
Canonical SMILES	OpenEye OEToolkits	2.0.7	[H]/N=C(/NC(=O)C)\N=C(\NS(=O)(=O)c1ccc(cc1)C(F)(F)F)/N2C[C@@H](C(=N2)c3ccc(cc3)Cl)c4ccccc4
InChI	InChI	1.06	InChI=1S/C26H22ClF3N6O3S/c1-16(37)32-24(31)33-25(35-40(38,39)21-13-9-19(10-14-21)26(28,29)30)36-15-22(17-5-3-2-4-6-17)23(34-36)18-7-11-20(27)12-8-18/h2-14,22H,15H2,1H3,(H3,31,32,33,35,37)/t22-/m1/s1
InChIKey	InChI	1.06	GYJPQNPVIJXXTA-JOCHJYFZSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB21537
Name	Monlunabant
Groups	investigational
Description	Monlunabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Monlunabant is a cannabinoid receptor antagonist. Monlunabant is under investigation in clinical trial NCT06542536 (A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men). Monlunabant has a monoisotopic molecular weight of 590.11 Da.
Synonyms	Monlunabant
CAS number	2712480-46-9

Related Resource References

Resource Name	Reference
PubChem	171370404, 164888943, 156861524

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.